A detailed history of Westside Investment Management, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 2,450 shares of ATAI stock, worth $2,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,450
Previous 2,450 -0.0%
Holding current value
$2,792
Previous $4.72 Million 30.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

SELL
$1.17 - $2.7 $58 - $135
-50 Reduced 2.0%
2,450 $4.44 Million
Q4 2022

Jan 31, 2023

BUY
$2.38 - $3.55 $3,927 - $5,857
1,650 Added 194.12%
2,500 $6,000
Q2 2022

Jul 15, 2022

BUY
$3.03 - $5.32 $757 - $1,330
250 Added 41.67%
850 $3,000
Q1 2022

Apr 25, 2022

BUY
$4.66 - $7.66 $233 - $383
50 Added 9.09%
600 $3,000
Q3 2021

Oct 27, 2021

BUY
$13.62 - $19.48 $7,491 - $10,714
550 New
550 $8,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.